Skip to content

Multimodal portal venography in liver cirrhosis: a prospective study

Multimodal portal venography in liver cirrhosis: a prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDC-16009986
Enrollment
Unknown
Registered
2016-11-23
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

Gold Standard:
Index test:

Sponsors

Beijing Shijitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with liver cirrhosis, with or without gastrointestinal bleeding

Exclusion criteria

Exclusion criteria: 1. exclusion of CT examination: (1) patient who is allergic to any component of Iodine contrast agents; (2) patient with hyperthyroidism or malignant thyroid tumor; (3) Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; (4) Pregnant or maybe pregnant woman; (5) Patient without good consciousness who may not complete the examination; (6) Patient with serious heart failure(NYHA 3-4); (7) patient with other X-ray examination within 72 hours to 7days before the contrast enhanced CT examination; (8) patient with other clinical trial within 30 days before the contrast enhanced CT examination; 2. Exclusion of MR examination: (1) patient who is allergic to any component of gadolinium contrast agents; (2) Patient with severe damage of renal function, defined as GFR<30mL/min1.73m2; (3) Patient with pacemaker, heart valve or other implants which cannot approach strong magnetic field; (4) patients with claustrophobia.

Design outcomes

Primary

MeasureTime frame
image qualitiy;portal vein and collateral veins;

Countries

China

Contacts

Public ContactRengui Wang

Beijing Shijitan Hospital, Capital Medical University

blazing2000@163.com+86 13911870396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026